CAS:1884201-71-1
纯度:98.15%
种属:Humanized
运输条件:Shipping with dry ice.
储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.
产品活性:Mirikizumab (LY3074828) 是一种人源化 IgG4 单克隆抗体,靶向白介素 23 的 p19 亚基。Mirikizumab 可用于溃疡性结肠炎的研究。
生物活性:Mirikizumab (LY3074828)是一种人源化IgG4单克隆抗体,靶向白介素23的p19亚基。Mirikizumab可用于溃疡性结肠炎的研究[1]。
参考文献:[1]. Jefremow A, et al. Some are More Equal: Targeting IL 12 and 23 in IBD - A Clinical Perspective. Immunotargets Ther. 2020 Nov 26;9:289-297.